BACKGROUND: Rectal sexually transmitted infections (STI) have been associated with human immunodeficiency virus (HIV) diagnosis, but inferring a causal association requires disentangling them from receptive anal intercourse (RAI). METHODS: We conducted a stratified case-control study by frequency matching 4 controls to each case within year using clinical data from men who have sex with men (MSM) attending the Seattle STD Clinic 2001 to 2014. Cases were MSM with a new HIV diagnosis and negative HIV test at 12 months or less. Controls were HIV-negative MSM. All included men had rectal STI testing, tested negative for syphilis, and had complete sexual behavior data. We categorized men by RAI: (1) none; (2) condoms for all RAI; (3) condomless RAI only with HIV-negative partners; and (4) condomless RAI with HIV-positive or unknown-status partners. We created 3 logistic regression models: (1) 3 univariate models of concurrent rectal gonorrhea, rectal chlamydia, and rectal STI in 12 months or less with new HIV diagnosis; (2) those 3 infections, plus age, race, year, number of sexual partners in 2 months or less, and methamphetamine use; and (3) model 2 with RAI categories. We calculated the population attributable risk of rectal STI on HIV diagnoses. RESULTS: Among 176 cases and 704 controls, rectal gonorrhea, chlamydia and rectal STI in 12 months or less were associated with HIV diagnosis. The magnitude of these associations attenuated in the second model, but persisted in model 3 (gonorrhea: adjusted odds ratio [aOR], 2.3; 95% confidence interval [CI], 1.3-3.8; chlamydia: aOR, 2.5; 95% CI, 1.5-4.3; prior STI: aOR, 3.0; 95% CI, 1.5-6.2). One in 7 HIV diagnoses can be attributed to rectal STI. CONCLUSIONS: Rectal STI are independently associated with HIV acquisition. These findings support the hypothesis that rectal STI play a biologically mediated causal role in HIV acquisition and support screening/treatment of STI for HIV prevention.
BACKGROUND: Rectal sexually transmitted infections (STI) have been associated with human immunodeficiency virus (HIV) diagnosis, but inferring a causal association requires disentangling them from receptive anal intercourse (RAI). METHODS: We conducted a stratified case-control study by frequency matching 4 controls to each case within year using clinical data from men who have sex with men (MSM) attending the Seattle STD Clinic 2001 to 2014. Cases were MSM with a new HIV diagnosis and negative HIV test at 12 months or less. Controls were HIV-negative MSM. All included men had rectal STI testing, tested negative for syphilis, and had complete sexual behavior data. We categorized men by RAI: (1) none; (2) condoms for all RAI; (3) condomless RAI only with HIV-negative partners; and (4) condomless RAI with HIV-positive or unknown-status partners. We created 3 logistic regression models: (1) 3 univariate models of concurrent rectal gonorrhea, rectal chlamydia, and rectal STI in 12 months or less with new HIV diagnosis; (2) those 3 infections, plus age, race, year, number of sexual partners in 2 months or less, and methamphetamine use; and (3) model 2 with RAI categories. We calculated the population attributable risk of rectal STI on HIV diagnoses. RESULTS: Among 176 cases and 704 controls, rectal gonorrhea, chlamydia and rectal STI in 12 months or less were associated with HIV diagnosis. The magnitude of these associations attenuated in the second model, but persisted in model 3 (gonorrhea: adjusted odds ratio [aOR], 2.3; 95% confidence interval [CI], 1.3-3.8; chlamydia: aOR, 2.5; 95% CI, 1.5-4.3; prior STI: aOR, 3.0; 95% CI, 1.5-6.2). One in 7 HIV diagnoses can be attributed to rectal STI. CONCLUSIONS: Rectal STI are independently associated with HIV acquisition. These findings support the hypothesis that rectal STI play a biologically mediated causal role in HIV acquisition and support screening/treatment of STI for HIV prevention.
Authors: Colleen F Kelley; Adam S Vaughan; Nicole Luisi; Travis H Sanchez; Laura F Salazar; Paula M Frew; Hannah L F Cooper; Ralph Diclemente; Carlos del Rio; Patrick S Sullivan; Eli S Rosenberg Journal: AIDS Res Hum Retroviruses Date: 2015-03-25 Impact factor: 2.205
Authors: Katherine C Scott; Susan Philip; Katherine Ahrens; Charlotte K Kent; Jeffrey D Klausner Journal: J Acquir Immune Defic Syndr Date: 2008-05-01 Impact factor: 3.731
Authors: Kyle T Bernstein; Julia L Marcus; Giuliano Nieri; Susan S Philip; Jeffrey D Klausner Journal: J Acquir Immune Defic Syndr Date: 2010-04-01 Impact factor: 3.731
Authors: Nicola M Zetola; Kyle T Bernstein; Ernest Wong; Brian Louie; Jeffrey D Klausner Journal: J Acquir Immune Defic Syndr Date: 2009-04-15 Impact factor: 3.731
Authors: Kathleen E Moriarty; Eddy R Segura; Williams Gonzales; Jordan E Lake; Robinson Cabello; Jesse L Clark Journal: LGBT Health Date: 2019-10 Impact factor: 4.151
Authors: Ryan Colby Passaro; Eddy R Segura; Amaya Perez-Brumer; Jeanne Cabeza; Silvia M Montano; Jordan E Lake; Jorge Sanchez; Javier R Lama; Jesse L Clark Journal: Sex Transm Dis Date: 2018-09 Impact factor: 2.830
Authors: Ronnie M Gravett; Andrew O Westfall; Edgar T Overton; Kachina Kudroff; Christina A Muzny; Ellen F Eaton Journal: Int J STD AIDS Date: 2020-01-28 Impact factor: 1.359
Authors: Julia C Dombrowski; Michael R Wierzbicki; Lori M Newman; Jonathan A Powell; Ashley Miller; Dwyn Dithmer; Olusegun O Soge; Kenneth H Mayer Journal: Clin Infect Dis Date: 2021-09-07 Impact factor: 9.079
Authors: Daniel Resnick; Knashawn Morales; Robert Gross; Danielle Petsis; Danielle Fiore; Annet Davis-Vogel; David Metzger; Ian Frank; Sarah Wood Journal: AIDS Patient Care STDS Date: 2021-01 Impact factor: 5.078
Authors: Christine M Khosropour; Julia C Dombrowski; Lucia Vojtech; Dorothy L Patton; Lee Ann Campbell; Lindley A Barbee; Michaela C Franzi; Kevin Hybiske Journal: Sex Transm Dis Date: 2021-12-01 Impact factor: 2.830